Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single-dose GZR4

Phase 1 Completed 43 enrolled Gan and Lee Pharmaceuticals, USA

RandomizedParallel-groupSingle-blindTreatment

Summary

This trial is conducted in China. The aim of this trial is to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of single-dose GZR4.

Timeline

Start: 2022-08-29
Primary completion: 2023-03-24
Completion: 2023-03-24

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	GZR4	Unknown	—	Subcutaneous

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single-dose GZR4

Summary

Timeline

Drugs

Indications